在携带FLT3-ITD突变的AML患者中N-MYC癌基因表达的转移
Konstantin Bogdanov1, Ekaterina Kudryavtseva1, Yulia Fomicheva1
1Almazov National Medical Research Centre, 2 Akkuratova Str., Saint Petersburg 197341, Russia.
概括
在急性髓性白血病 (AML) 中的FLT3-ITD突变会提高N-MYC瘤基因表达,独立于FLT3-ITD水平. 这表明N-MYC可能会导致AML的治疗耐药性和疾病进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 类似FMS的铁酶3 (FLT3) 突变在急性髓性白血病 (AML) 中很常见.
- FLT3突变影响基因表达,影响白血病发生.
- 通常与神经母细胞瘤相关的基因在AML中研究较少.
研究的目的:
- 研究AML中神经母细胞瘤相关基因的表达.
- 评估FLT3-ITD突变与AML中的N-MYC癌基因表达之间的关系.
- 评估N-MYC表达与FLT3-ITD等位体负载和治疗反应相关的临床意义.
主要方法:
- 在初级AML患者的基因表达分析.
- 基于FLT3突变状态和型的N-MYC表达的比较.
- 在N-MYC表达和FLT3-ITD等位荷载之间的相关性分析.
- 在AML治疗期间对N-MYC表达的纵向监测.
主要成果:
- 在患有FLT3-ITD突变的AML患者中,N-MYC瘤基因表达显著更高 (超过3倍),与其他突变或正常型相比 (p = 0.03946).
- 与其他研究的基因不同,N-MYC表达显示出与FLT3-ITD等位基因负载的弱相关性或独立性 (p = 0.0405).
- 治疗后N-MYC表达的升高持续了长达三个月,尽管一些患者的FLT3-ITD等位体负载下降.
结论:
- N-MYC基因上调是一种与AML中的FLT3-ITD突变相关的独特特征.
- N-MYC表达似乎独立于FLT3-ITD等位体负载,这表明了替代的调节机制.
- 治疗后持续的N-MYC升高可能表明新出现的治疗耐药性和AML进展.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K


